Stem Cells From Deceased Donors; Cancer Screening Lags; Blood Type and Cancer Risk

Stem Cells From Deceased Donors; Cancer Screening Lags; Blood Type and Cancer Risk

(MedPage Today) -- A first-of-its-kind clinical trial will evaluate stem cell transplants with cells from deceased donors. (University of Utah Huntsman Cancer Institute) Will President Trump's executive order to lower drug prices wreak "enormous...

A step closer to the confident production of blood stem cells for regenerative medicine

Stem cells can produce any other cell type, it is just a matter of telling them in the right way. From a biological perspective, this means activating the proper genetic program by pressing the right keys, that is, the right genes, at the right moment. Quite often, blood cancer patients require the replacement of their blood stem cells in the bone marrow, the tissue producing blood cells where their cancer grows.

NEW LITERATURE With stem cells, Alina Lindermuth succeeds in bridging the gap between threatening science fiction scenario, current social portrait and intense relationship novel. After 300 pages, she releases the readership without morals and flat solutions, but with a completely new look at nature and trees. Judith Hoffmann, Ö1 Alina Lindermuth Stem Cells Reading Moderation: Felix Kucher Tuesday, 10. 06. 2025 19.30 Ronja and Elio share their f…

Advancing Toward Reliable Blood Stem Cell Production for Regenerative

In a groundbreaking study that could redefine the future of regenerative medicine and blood disorder treatments, researchers from the Josep Carreras Leukaemia Research Institute have identified a precise set of genes that can transform embryonic stem cells into fully functional hematopoietic stem and progenitor cells (HSPCs). This work, led by Dr. Anna Bigas and first-authored by Dr. Luis Galan Palma, represents a significant advance in the purs…